. 2022 Jun 22;26:61–65. doi: 10.1016/j.jdcr.2022.06.008

Table I.

Reported cases of erythroderma secondary to leukemia cutis

Report	Age, sex	Leukemia subtype	Chronology of erythroderma	Recurrent erythroderma	Treatment	Outcome
Su et al,⁶ 1984	NR, 2 cases	Chronic lymphocytic leukemia	NR	NR	NR	NR
De Coninck et al,⁷ 1986	57, M	Acute myelomonocytic leukemia	1st: Aleukemic LC, 2nd: concomitant	Yes	2nd: Vincristine, adriamycin, prednisone, and cytosine arabinoside	1st: Spontaneous regression. 2nd: Regression 1 wk, death 1 mo
Sigurdsson et al,⁸ 1996	NR	Chronic lymphocytic leukemia	NR	NR	NR	Death
Jeong et al,⁹ 2009	82, M	T-cell prolymphocytic leukemia	Concomitant	NR	Fludarabine and prednisone	Death, 2 wk
Raj et al,¹⁰ 2011	75, M	Chronic myeloid leukemia	Concomitant	Yes	Imatinib	Resolution, 3 mo
Novoa et al,¹¹ 2015	65, F	Pre-B-cell acute lymphoblastic leukemia	After diagnosis	NR	Hospice	Death
Coen and Serratrice,¹² 2016	74, M	Atypical chronic lymphocytic leukemia	Concomitant	No	Conservative management	Asymptomatic for 2 years then lost to f/u
Donaldson et al,¹³ 2019	50, F	Acute myeloid leukemia	After diagnosis	No	Reinduction therapy with high-dose cytarabine	Resolution, 2 wk
Current case, 2022	88, M	Chronic myelomonocytic leukemia	After diagnosis	No	Topical steroids, azacitidine	Resolution, 4 mo

F, Female; f/u, follow-up; LC, leukemia cutis; M, male; NR, not reported.